Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 6212604
- CPT
- -
- Packaging group
- 56
- Unit
- Tablette(n)
- Composition
- ruxolitinibum 10 mg ut ruxolitinibi phosphas, lactosum monohydricum 142.9 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, hydroxypropylcellulosum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 0.65 mg.
Articles (1)
Jakavi 10 mg, Tabletten
Tabletten
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ruxolitinibum
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
ruxolitinibi phosphas
|
- | Substance | WIZUS |
|
lactosum monohydricum
|
142.9 MG | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
carboxymethylamylum natricum A
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
povidonum K 30
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
natrium
|
0.65 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 3435.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2017
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 62126
- Drug name
- Jakavi, Tabletten
- Galenic form
- TAB
- ATC Code
- L01EJ01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 27/12/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- JAKAVI cpr 10 mg 56 pce
- Description (DE)
- JAKAVI Tabl 10 mg 56 Stk
- Market launch
- 10/06/2015
- Narcotic (BTM)
- No